Michael Klibaner

1.8k total citations · 1 hit paper
20 papers, 1.4k citations indexed

About

Michael Klibaner is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Michael Klibaner has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Michael Klibaner's work include Blood Pressure and Hypertension Studies (7 papers), Heart Failure Treatment and Management (5 papers) and Cardiovascular Function and Risk Factors (3 papers). Michael Klibaner is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Heart Failure Treatment and Management (5 papers) and Cardiovascular Function and Risk Factors (3 papers). Michael Klibaner collaborates with scholars based in United States, United Kingdom and Sweden. Michael Klibaner's co-authors include Harry Haber, Anthony L. Pucillo, Carlos Macaya, Carl J. Pepine, Blair J. O’Neill, Bertram Pitt, Thomas J. Wargovich, Andrew C. G. Uprichard, G.B. John Mancini and Harald Mudra and has published in prestigious journals such as Circulation, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Michael Klibaner

20 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease

1996 837 citations G.B. John Mancini, Carlos Macaya et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Klibaner United States	12	1.0k	322	258	253	114	20	1.4k
Andrew C. G. Uprichard United States	12	1.1k 1.0×	278 0.9×	273 1.1×	194 0.8×	144 1.3×	31	1.4k
Roland E. Schmieder Germany	16	806 0.8×	326 1.0×	157 0.6×	404 1.6×	73 0.6×	33	1.4k
Giulia Dell’Omo Italy	18	722 0.7×	209 0.6×	134 0.5×	188 0.7×	71 0.6×	47	1.3k
Michael F. Oliver United Kingdom	20	656 0.6×	258 0.8×	76 0.3×	544 2.2×	110 1.0×	37	1.3k
J L Richard France	9	832 0.8×	287 0.9×	111 0.4×	270 1.1×	87 0.8×	16	1.3k
B. Pitt United States	14	1.4k 1.4×	607 1.9×	154 0.6×	409 1.6×	235 2.1×	41	2.0k
Gudrun Lamm Austria	14	957 0.9×	315 1.0×	80 0.3×	631 2.5×	183 1.6×	43	1.7k
B Solymoss Canada	25	831 0.8×	344 1.1×	131 0.5×	546 2.2×	232 2.0×	82	1.8k
Salvatore Turco Italy	16	391 0.4×	401 1.2×	117 0.5×	217 0.9×	140 1.2×	32	1.1k
Michael Böhm Germany	10	608 0.6×	203 0.6×	248 1.0×	221 0.9×	36 0.3×	18	1.3k

Countries citing papers authored by Michael Klibaner

Since Specialization

Citations

This map shows the geographic impact of Michael Klibaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Klibaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Klibaner more than expected).

Fields of papers citing papers by Michael Klibaner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Klibaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Klibaner. The network helps show where Michael Klibaner may publish in the future.

Co-authorship network of co-authors of Michael Klibaner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Klibaner. A scholar is included among the top collaborators of Michael Klibaner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Klibaner. Michael Klibaner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Colucci, Wilson S., Theodore J. Kolias, Kirkwood F. Adams, et al.. (2007). Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction. Circulation. 116(1). 49–56. 121 indexed citations

Batisky, Donald L., Jonathan M. Sorof, Jennifer Sugg, et al.. (2007). Efficacy and Safety of Extended Release Metoprolol Succinate in Hypertensive Children 6 to 16 Years of Age: A Clinical Trial Experience. The Journal of Pediatrics. 150(2). 134–139.e1. 45 indexed citations

Deedwania, Prakash, Thomas D. Giles, Michael Klibaner, et al.. (2005). Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HF. American Heart Journal. 149(1). 159–167. 97 indexed citations

Falkner, Bonita, Jennifer Sugg, Jonathan M. Sorof, & Michael Klibaner. (2005). Efficacy and safety of a long-acting beta blocker, extended release metoprolol succinate, in hypertensive children. American Journal of Hypertension. 18(5). A8–A8. 1 indexed citations

Trachtman, Howard, Rachel Frank, John D. Mahan, et al.. (2003). Clinical trial of extended-release felodipine in pediatric essential hypertension. Pediatric Nephrology. 18(6). 548–553. 49 indexed citations

Wikstrand, John, et al.. (2003). Pharmacokinetic Considerations of Formulation: Extended-Release Metoprolol Succinate in the Treatment of Heart Failure. Journal of Cardiovascular Pharmacology. 41(2). 151–157. 29 indexed citations

Jánosi, András, Jalal K. Ghali, Johan Herlitz, et al.. (2003). Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF. American Heart Journal. 146(4). 721–728. 36 indexed citations

Fisher, Lloyd D. & Michael Klibaner. (2001). Regulatory issues for Data and Safety Monitoring Committees. American Heart Journal. 141(4). 536–541. 5 indexed citations

Black, Henry R., W.J. Elliott, Michael A. Weber, et al.. (2001). One-Year Study of Felodipine or Placebo for Stage 1 Isolated Systolic Hypertension. Hypertension. 38(5). 1118–1123. 22 indexed citations

10.

Klibaner, Michael, et al.. (1996). Angiotensin converting enzyme inhibition, with quinapril, improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND study (trial on reversing endothelial dysfunction). Journal of the American College of Cardiology. 27(2). 19–19. 2 indexed citations

11.

Chan, Raymond C., Godtfred Holmvang, Robert E. Dinsmore, et al.. (1996). Baseline clinical and angiographic data in the quinapril ischemic event (QUIET) Trial. The American Journal of Cardiology. 78(9). 1011–1016. 12 indexed citations

12.

Mancini, G.B. John, Carlos Macaya, Blair J. O’Neill, et al.. (1996). Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease. Circulation. 94(3). 258–265. 837 indexed citations breakdown →

13.

Chan, Keith K. H., et al.. (1994). Effect of Food on the Relative Bioavailability of a Hypolipidemic Agent (CGP 43371) in Healthy Subjects. Journal of Pharmaceutical Sciences. 83(2). 264–266. 5 indexed citations

14.

Slomiany, Bronislaw L., et al.. (1991). GM₁ Ganglioside Protection Against Ethanol‐Induced Gastric Mucosal Injury. Alcoholism Clinical and Experimental Research. 15(2). 196–204. 11 indexed citations

15.

Klibaner, Michael, et al.. (1985). Delayed Fatal Pulmonary Hemorrhage Complicating Use of a Balloon Flotation Catheter. Angiology. 36(6). 358–362. 20 indexed citations

16.

Tracey, Kevin J., Michael J. O’Brien, Lester F. Williams, et al.. (1984). Signet ring carcinoma of the pancreas, a rare variant with very high CEA values. Digestive Diseases and Sciences. 29(6). 573–576. 22 indexed citations

17.

Klibaner, Michael, et al.. (1982). Tuberculous Abscess of the Pancreas. Gastroenterology. 83(4). 922–925. 57 indexed citations

18.

Klibaner, Michael, et al.. (1977). Resistance of the myocardium to adrenalin in rats adapted to hypoxia. Bulletin of Experimental Biology and Medicine. 84(3). 1229–1233. 1 indexed citations

19.

Nanaev, A. K. & Michael Klibaner. (1976). Metabolic disturbances and plasmorrhagia into myocardial cells injured by adrenalin. Bulletin of Experimental Biology and Medicine. 81(2). 283–285. 2 indexed citations

20.

Klibaner, Michael. (1972). Dynamics of alkaline phosphatase activity during healing of adrenalin. Bulletin of Experimental Biology and Medicine. 73(4). 403–405. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact